Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Bioporto AS's annualized positive value of Interest Expense for the quarter that ended in Dec. 2025 was €-1.08 Mil. Bioporto AS's average total debt for the quarter that ended in Dec. 2025 was €1.06 Mil. Therefore, Bioporto AS's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2025 was -102.07%.
Bioporto AS (FRA:2P4) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
Bioporto AS Effective Interest Rate on Debt % Related Terms
Bioporto AS Effective Interest Rate on Debt % Historical Data
* Premium members only.
The historical data trend for Bioporto AS's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioporto AS Effective Interest Rate on Debt % Chart
FRA:2P4 vs TMO, DHR, IDXX: Effective Interest Rate on Debt % Comparison
For the Diagnostics & Research subindustry, Bioporto AS's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioporto AS Effective Interest Rate on Debt % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bioporto AS's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where Bioporto AS's Effective Interest Rate on Debt % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Dec. 2025) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
What does a Effective Interest Rate on Debt % of -102.07% mean?
Bioporto AS (FRA:2P4) has a Effective Interest Rate on Debt % of -102.07% as of Dec. 2025. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Bioporto AS and its competitors.
Is Bioporto AS's Effective Interest Rate on Debt % too high?
Bioporto AS's current Effective Interest Rate on Debt % is -102.07%. Overall, Bioporto AS has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Bioporto AS's Effective Interest Rate on Debt % compare to TMO and DHR?
Bioporto AS's Effective Interest Rate on Debt % of -102.07% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Medical Diagnostics & Research company?
A good Effective Interest Rate on Debt % depends on the Medical Diagnostics & Research industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Bioporto AS and its competitors. Bioporto AS's current Effective Interest Rate on Debt % is -102.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioporto AS stock overvalued right now?
Bioporto AS (FRA:2P4) has a current Effective Interest Rate on Debt % of -102.07%. The stock's GF Value™ is €0.15, compared to a current price of €0.13 — trading 16.7% below its estimated fair value. The current Effective Interest Rate on Debt % is -102.07%. Bioporto AS's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Bioporto AS (FRA:2P4), the current Effective Interest Rate on Debt % is -102.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioporto AS (FRA:2P4) Overvalued in 2026?
Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued.
The current stock price of €0.13 is trading 16.7% below its estimated GF Value™ of €0.15.
Key valuation signals for FRA:2P4:
Effective Interest Rate on Debt %: -102.07%
GF Value™: €0.15 vs. price of €0.13 (16.7% below fair value)
No single metric tells the full story. See the FRA:2P4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
71GF Score
Get the complete analysis for FRA:2P4
Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2P4 has been successfully added to your 
